Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock Singapore S.E.
Equities
T14
CNE100000924
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.99 USD | 0.00% | -1.97% | -3.86% |
Sales 2024 * | 8.93B 1.23B | Sales 2025 * | 9.71B 1.34B | Capitalization | 21.76B 3.01B |
---|---|---|---|---|---|
Net income 2024 * | 1.18B 163M | Net income 2025 * | 1.41B 195M | EV / Sales 2024 * | 2.44 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.24 x |
P/E ratio 2024 * |
21.6
x | P/E ratio 2025 * |
18.1
x | Employees | 4,619 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 31.63% |
1 week | -1.97% | ||
Current month | -1.00% | ||
1 month | -0.50% | ||
3 months | +5.29% | ||
6 months | +10.56% | ||
Current year | -3.86% |
Managers | Title | Age | Since |
---|---|---|---|
Lei Wang
CEO | Chief Executive Officer | 53 | 22-08-21 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
42 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ping Zhang
BRD | Director/Board Member | 55 | 19-09-29 |
Yoke Pheng Liew
BRD | Director/Board Member | 68 | 20-06-04 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 1.99 | 0.00% | 92,600 |
24-04-17 | 1.99 | -1.00% | 70,800 |
24-04-16 | 2.01 | -0.50% | 100,000 |
24-04-15 | 2.02 | 0.00% | 308,400 |
24-04-12 | 2.02 | -0.49% | 271,300 |
Delayed Quote Singapore S.E., April 18, 2024 at 03:36 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+40.29% | 6.02B | |
-15.73% | 4.55B | |
-9.40% | 3.13B | |
-1.23% | 2.57B | |
+34.89% | 1.82B | |
-11.37% | 1.63B | |
-5.02% | 1.57B | |
-13.21% | 1.54B | |
+25.23% | 1.31B |
- Stock Market
- Equities
- 600329 Stock
- T14 Stock